Analysis of the lipid profile of elderly women in Curitiba - Parana;Análise do perfil lipídico de mulheres idosas em Curitiba - Paraná

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 5, 2008, Pages

  Krause, Maressa P ^a   Hallage, Tatiane ^a   Miculis, Cristiane Petra ^a   Gama, Mirnaluci Paulino Ribeiro ^a   Da Silva, Sergio G ^a  

^a NONE

Author keywords

Aging; Dyslipidemias therapy; Risk factors

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GERIATRIC CARE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PREVALENCE; RISK FACTOR; SELF REPORT; WOMEN'S HEALTH;

AGED; ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; BRAZIL; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MIDDLE AGED; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 44849088200     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000500004     Document Type: Article

References (35)

1. Mansur AP, Favarato D, Souza MFM, Avakian SD, Aldrighi JM, César LAM, et al. Tendência da mortalidade por doenças circulatórias no Brasil de 1979 a 1996. Arq Bras Cardiol. 2001; 76: 497-503.
2. Brasil. Ministério da Saúde. Secretaria Executiva. Datasus. Informações de Saúde. Indicadores e dados básicos do Brasil 2006. [citado 2007 junho 26]. Disponível em: www.datasus.gov.br/ idb.
3. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Final Report. Circulation. 2002; 106: 3143-421.
4. Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995; 274 (7): 539-44.
5. Lessa I, Conceição JL, Souza ML, Oliveira V, Carneiro J, Melo J, et al. Prevalência de dislipidemias em adultos da demanda laboratorial de Salvador, Brasil. Arq Bras Cardiol. 1997; 69 (6): 395-400.
6. Lessa I, Conceição JL, Mirabeau L, Carneiro J, Melo J, Oliveira V, et al. Prevalência de dislipidemias na demanda laboratorial de três diferentes prestadoras de assistência. Arq Bras Cardiol. 1998; 70 (5): 331-5.
7. Moreira RO, Santos RD, Martinez L, Saldanha FC, Pimenta JLAC, Feijoo J, et al. Perfil lipídico de pacientes com alto risco para eventos cardiovasculares na prática clínica diária. Arq Bras Endocrinol Metab. 2006; 50 (3): 481-9.
8. Vacanti LJ, Santos SCM, Fujita AM, Lima DS, Lopes AF, Vetorazi R, et al. A baixa taxa de obtenção da meta do LDL colesterol numa população de baixa renda. Arq Bras Cardiol. 2005; 85 (3): 162-5.
9. Nagashima H, Kasanuki H. The status of lipid management in 1836 patients with coronary artery disease: a multicenter survey to evaluate the percentage of japonese coronary artery disease patients achieving the target low-density lipoprotein cholesterol level specified by the Japan Atherosclerosis Society. J Atheroscler Thromb. 2005; 12: 338-42.
10. Arnett DK, Jacobs DR Jr, Luepker RV, Blackburn H, Armstrong C, Claas SA. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: The Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation. 2005; 112: 3884-91.
11. Sociedade Brasileira de Cardiologia. IV Diretrizes Brasileiras sobre Dislipidemias e Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007; 88 (supl I): S1-19.
12. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-52.
13. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000; 343: 16-22.
14. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999; 99 (6): 779-85.
15. Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004; 110: 227-39.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
17. Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006; 113: 647-56.
18. Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004; 110: 2824-30.
19. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001; 285: 1585-91.
20. Johnsen SH , Mathiesen EB , Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression :a follow-up study of 1952 persons with carotid atherosclerosis - The Tromsø Study. Circulation. 2005; 112: 498-504.
21. Cervato AM, Mazzilli RN, Martins IS, Marucci MFN. Dieta habitual e fatores de risco para doenças cardiovasculares. Rev Saúde Pública. 1997; 31 (3): 227-35.
22. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109 (Suppl III): III-2-III-7.
23. Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, et al. Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001; 21: 955-60.
24. Alencar YMG, Carvalho Fo ET, Paschoal SMP, Curiati JAE, Ping WC, Litvo J. Fatores de risco para aterosclerose em uma população idosa ambulatorial na cidade de São Paulo. Arq Bras Cardiol. 2000; 74 (3): 181-8.
25. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004; 350: 1495-504.
26. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352: 1425-35.
27. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease: an American Heart Association National Study. Circulation. 2004; 109: 573-9.
28. Mosca L, Linfante AH, Benjamim EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005; 111: 499-510.
29. Oliveira AP, Mancini Fo J. Perfil nutricional e lipídico de mulheres na pósmenopausa com doença arterial coronariana. Arq Bras Cardiol. 2005; 84 (4): 325-9.
30. Mansur AP, Mattar APL, Tsubo CE, Simão DT, Yoshi FR, Daci K. Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. Arq Bras Cardiol. 2001; 76 (2): 115-8.
31. Cheng AYY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr Opin Cardiol. 2006; 21: 400-4.
32. Martinez TLR, Santos RD, Armaganijan D, Torres KP, Loures-Vale A, Magalhães ME, et al. National alert campaign about increased cholesterol: determination of cholesterol levels in 81,262 Brazilians. Arq Bras Cardiol. 2003; 80: 635-8.
33. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics - 2007 update: a report from the American American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 115: 69-171.
34. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah: a screening analysis. Hypertension. 1991; 17: 969-76.
35. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in woman. Neurology. 2007; 68: 556-62.